Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-058224
Filing Date
2025-06-10
Accepted
2025-06-10 17:41:17
Documents
1
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517621-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2517621-5_4seq1.xml 4 4044
  Complete submission text file 0001104659-25-058224.txt   5587
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Issuer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TREVENA, INC. 1018 WEST 8TH AVENUE KING OF PRUSSIA PA 19406
Business Address
Phillips Anne M. (Reporting) CIK: 0001627680 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41742 | Film No.: 251038241